TNThiyahiny Sunil Navaratinaraja

Thiyahiny Sunil Navaratinaraja

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Thiyahiny Sunil Navaratinaraja has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Treatment pattern and adverse effects of antiseizure medications among adult patients with epilepsy: A single centre observational cross-sectional study in Northern Sri Lanka

    by Yalini Guruparan, Ajantha Keshavaraj, Thiyahiny S Navaratinaraja

    Background: Antiseizure medications (ASMs) are essential for seizure control, but they are also associated with a range of adverse effects that may affect treatment outcomes. Objective: This study aimed to evaluate the treatment pattern and adverse effects of ASMs among adult patients with epilepsy who were followed up at a tertiary-care hospital in Northern Sri Lanka. Methods: A descriptive cross-sectional study was conducted among adult patients on ASMs for ≥3 months who were receiving follow-up at Teaching Hospital Jaffna. Data were collected over four months using a pretested interviewer-administered questionnaire. Chi-square test and logistic regression were performed to determine the significance between groups and the association of independent variables, respectively. A p-value of ≤0.05 was considered statistically significant. Results: Data from 213 participants was analysed. The mean age was 36.27 ± 0.92 years, and the male-to-female ratio was almost 1. Nearly two-thirds of participants (64.8%) were on dual or polytherapy. Older ASMs were predominantly prescribed (74.5%). A total of 333 adverse effects were reported, giving a point prevalence of 68.5% and a rate of 1.6 adverse effects per person. Sedation (27%), memory impairment (24%), and dizziness (21%) were the most common adverse effects. Advancing age (adjusted OR (AOR): 4.3, 95% CI 1.87 to 10.29, p<0.001), early onset of epilepsy (AOR: 0.35, 95% CI 0.14 to 0.87, p=0.023), and the use of multiple ASMs (AOR: 2.7, 95% CI 1.4 to 5.3, p=0.003) were associated with the occurrence of adverse effects. Carbamazepine, clobazam and valproic acid were significantly (p<0.05) associated with one or more common adverse effects. Conclusion: Most patients in this study received older antiseizure medications and polytherapy. A high burden of medication-related adverse effects was also observed. Regular review and reconciliation of treatment and improving access to better-tolerated medication would reduce the medication-related burden among patients with epilepsy.

  • Open Access

    Effect of Gymnema lactiferum tea brew on type 2 diabetes mellitus: A double-blind, randomised active-controlled phase III clinical trial

    by Kulanayagam Karthigesu, Sivansuthan Sivapalan, Surenthirakumaran Rajendra, Thiyahiny Sunil Navaratinaraja, Vithegi Kesavan, Sirimal Premakumara


  • Open Access

    Lipid Levels of Healthy Adults in Jaffna district, Northern Province of Sri Lanka: An Analysis of Secondary Data

    by Thiyahiny S. Navaratinaraja, Raveendran Gajanthan, Rathai Janahan, Vathulan Sujanitha, Sivapalan Sivansuthan, Ratnasabapathipillai Kesavan

    Abnormal lipid profile is considered as an important contributor to cardiovascular diseases among South Asians. Sri Lanka is a multiethnic South Asian nation and differences in ethnicity may influence the pattern of lipid profile. The aim of this paper is to analyse the lipid levels of healthy adults of a predominantly Sri Lankan Tamil population in the Northern Sri Lanka and compare it with the lipid levels of different ethnic groups reported in the literature. It was a cross-sectional analysis of secondary data of 500 healthy adults who were the controls of a larger study on the lipid profile of diabetic and non-diabetic patients. Cut-off values for desirable lipid levels used in this study were determined according to national and international guidelines. Chi-squared test, independent t-test/ Mann–Whitney U-test and one-way analysis of variance were used to determine the statistical significance and a p-value <0.05 was considered significant.The majority (61.4%) were women and the mean age was 54.8±12.6 years. Mean lipid levels were within normal range except HDL cholesterol (HDL-C) in women (46.6± ±10.6 mg/dL). Desirable lipid levels were observed in majority of the participants (58%-80%) except HDL-C among women (32%). Half of the study population had a desirable total cholesterol: HDL-C ratio (50.8%). Significant difference between men and women was observed for HDL-C (p<0.05). The HDL-C levels and total cholesterol: HDL-C ratio of Jaffna population were comparable to those of South Asian populations. Further studies are needed to determine the clinical implication of these observations.


  • Open Access

    Effectiveness of inhaled therapies in asthma among adults in Northern Sri Lanka, a low and middle-income country: A prospective observational study

    by Yalini Guruparan, Thiyahiny S Navaratinaraja, Gowry Selvaratnam, Shalini Sri Ranganathan

    Background: Currently inhaled corticosteroids (ICS) alone, or in combined with inhaled long- acting beta 2 -agonist (LABA) is recommended for chronic asthma. Objective: This study aimed to assess the effectiveness of inhaled therapies in a cohort of adult patients with asthma who were receiving treatment in a tertiary hospital in the Northern Sri Lanka. Methods: A prospective cohort study was carried out among adult patients with asthma on inhaled medications for at least three months. Participants were followed up for six months with two follow-up interviews three months apart. Primary outcome measure was asthma control which was assessed by a locally validated asthma control patient-reported outcome measure (AC-PROM). Secondary outcome measures were use of short-acting beta 2 -agonists, number of nebulisations and number of hospitalisations. Chi-squared test was used to determine the significance of differences in outcome measures between the two groups. Logistic regression was performed to determine the association between asthma control and socio-demographic factors. A p-value ≤ 0.05 was considered statistically significant. Results: Data from 1094 participants were analysed. Majority were females (73%) and belonged to age group >60 years (60%). Ratio between ICS monotherapy and combined therapy with ICS and LABA (ICS/LABA) was 3:1. A progressive improvement in asthma control was observed in both groups which was significant in those on ICS monotherapy (p2 -agonist (p2 -agonist (LABA) are recommended for the treatment of asthma. However, availability and affordability limit the use of inhaled medications in low and middle-income countries, particularly the combined therapy with ICS and LABA (ICS/LABA). What this study adds: This study was conducted in a real-life clinical setting to compare the effectiveness of ICS monotherapy and ICS/LABA. We found that close monitoring and improved communication positively impacted asthma control and exacerbations in both ICS monotherapy and ICS/LABA. These changes were significant in those on ICS monotherapy, but not in those on ICS/LABA. How this study might affect research, practice, or policy: Our study highlighted the importance of non-pharmacological approaches in the management of asthma. Promoting non-pharmacological approaches in routine clinical practice is likely to improve asthma control and reduce the need for escalation of treatment leading to improved quality of life and reduced healthcare costs.


  • Open Access

    Potential Drug–Drug Interactions Among Hospitalised Elderly Patients in Northern Sri Lanka, A Lower Middle-Income Country: A Retrospective Analysis

    by Thiyahiny S. Navaratinaraja, Thirunavukarasu Kumanan, Suthasini Siraj, Nadarajah Sreeharan

    Background and Objectives Elderly individuals are more vulnerable to potential drug–drug interactions (pDDIs) as age-related physiological changes, polypharmacy and hospitalisations are known to increase the risk of pDDIs. The aims of this study were to assess the impact of hospitalisation and other associated factors on pDDIs in elderly patients, in a resource-limited setting. Methods This is a retrospective analysis of data of elderly patients (aged ≥ 65 years) admitted to the medical units of Jaffna Teaching Hospital. Preadmission and post-admission data were collected from clinic and hospital records, respectively. The British National Formulary was used to identify and categorise pDDIs. Point prevalence of pDDIs in elderly patients and the total number of pDDIs before and after hospitalisation were estimated. Factors contributing to pDDIs were determined by univariate and multivariable logistic regression. Results Two hundred and eighty-eight hospitalised elderly patients with a median age of 71 years (interquartile range 67–76 years) showed a significant increase in the prevalence of pDDIs post-admission compared with the preadmission values (77.1% vs 61.5%; p < 0.001) associated with an increase in total pDDIs (377 vs 488; p < 0.001) where the majority (> 75%) were potential pharmacodynamic interactions. An unadjusted analysis showed a significant association between pDDI and polypharmacy [taking five or more medications] (odds ratio [OR] = 14.17; 95% confidence interval [CI] 7.41–27.10), the presence of more than three underlying medical conditions (OR 4.14; 95% CI 1.70–10.06), ischaemic heart disease (OR 3.25; 95% CI 1.78–5.94) and asthma (OR 8.14; 95% CI 2.46–26.88). However, when adjusted for confounders only polypharmacy (OR 14.10; 95% CI 6.50–30.60) and the presence of underlying asthma (OR 11.61; 95% CI 2.82–47.85) were associated with pDDIs. Conclusions The prevalence of pDDIs among elderly patients was high and increased with hospital admissions. Polypharmacy and relevant comorbidities were contributory factors. Increased awareness of the potential for pDDIs through appropriate training and simple measures including a proper drug history, creating a bespoke pDDI list and frequent medication reviews by healthcare professionals would help to mitigate pDDIs in resource-limited and technology-limited settings.


  • Open Access

    Chronic illnesses and polypharmacy in elderly patients: A hospital-based study in Northern Sri Lanka

    by S. N. Thiyahiny, T. Kumanan, R. Surenthirakumaran

    Population aging and multiple pathology among older people have increased medicines use in elderly. Aim of this study was to evaluate chronic illnesses and polypharmacy and to determine factors associated with polypharmacy among hospitalized elderly at Teaching Hospital-Jaffna. This was a cross sectional, descriptive study. Elderly and polypharmacy were defined as ≥65years and concomitant use of ≥6 medications for ≥1 month respectively. Data were collected from bedhead-tickets of 288 elderly patients using data extraction sheet. Chi-squared and paired t-test were performed to determine the level of significance and unadjusted odd ratios were calculated to determine the association between polypharmacy and common chronic illnesses. A p value 10% of the patients. Lipid-modifying (80.9%) and antithombotic agents (76.4%) were the top two subgroups prescribed to elderly. Polypharmacy was substantially increased with increasing number of chronic illnesses (p<0.05). Significant association (p<0.05) was found between polypharmacy and coronary heart disease, anaemia, heart failure, asthma and diabetes mellitus. Significantly greater number of medications were prescribed on discharge compared to admission (p<0.05). This study concluded that polypharmacy was common among hospitalized elderly and increases with hospitalization. There was increased tendency to prescribe antithrombotic and lipid-modifying agents. These findings indicate the need for medication reconciliation and review in elderly patient. Further studies targeting wider population are needed to determine the appropriateness of polypharmacy in elderly.


  • Changing Trend in the Availability of Key Essential Medicines for Children in a Resource-Limited Country

    by Shalini Sri Ranganathan, S. N. Thiyahiny, R. Balasubramaniam, B. V. S. H. Beneragama


  • Open Access

    Prescription of antibiotics among paediatric outpatients at Teaching Hospital-Jaffna

    by S. N. Thiyahiny, M. G. Sathiadas, R. Surenthirakumaran, S. Layanthini

    Aim of the study was to evaluate prescription of antibiotics among paediatric outpatients at Teaching Hospital-Jaffna.It was a cross sectional descriptive study carried out among the paediatric outpatients in July and August 2014. A data extraction form was developed based on WHO data collection forms and was used to collect the data. Nine drug use indicators which include modified core and complementary WHO drug use indicators and indicators developed by the investigators were used to evaluate antibiotic prescription. Descriptive statistics were used for data analysis.Out of 1181 prescriptions of paediatric outpatients, 825 (69.9%) had antibiotics. Average number of antibiotics per prescription was 0.7. Percentage of antibiotics prescribed by generic name, from essential medicine list and for common conditions were 97%, 100% and 91.4% respectively. Percentage of prescriptions with the documentation of reason for prescribing an antibiotic was 97%. Only 3.4% antibiotic prescriptions were complete. Percentage of drug cost spent on antibiotics was 33.2% and average antibiotic cost per encounter was 54.34 Sri Lankan rupees. The most frequently prescribed antibiotic group was penicillins (53.3%). The most common indication for antibiotics was respiratory tract infection (70.3%). Majority of the antibiotics (74%) were prescribed in paediatric dosage form.Good prescribing practice was observed for prescribing in generic name, prescribing the antibiotic from essential medicines list, prescribing for common conditions, documentation of reason for prescribing and prescription of paediatric dosage forms. The completeness of antibiotic prescriptions was poor and needs special attention to improve. The drug use indicators are useful tools to evaluate the antibiotic prescriptions in a setting as well as among different settings.


  • Open Access

    Medicines use in hospitalised children: current status and outcome after an intervention

    by S N Thiyahiny, M G Sathiadas, K Sanchayan, C Vamadevan, R Balasubramaniam, S Sri Ranganathan

    Challenges in rational use of medicines (RUM) in children are different from that of adults. In Sri Lanka, data on RUM in children are limited. To assess the current status and to investigate effectiveness of an intervention in improving RUM in children. Non-randomised controlled before and after study design was employed. Study settings were one paediatric unit in two Teaching Hospitals one for intervention (IU) and the other as a control (CU) unit. After assessing the current status in both units, a combined intervention (one-time training and distribution of a paediatric formulary) was offered to IU and medicine use was re-assessed in both units three months and one year after intervention. Fourteen indicators (7 WHO and 7 developed by investigators) were employed in the assessment. Any improvement was analysed using percentage changes, Chi-square or t tests as appropriate. A total of 1134 charts, 735 (3197 medicines) in IU and 399 (1539 medicines) in CU were subjected to analysis. At base level, of the 14 indicators, 9 were assessed satisfactory in both units. Four could not be assessed without knowing the clinical setting. The remaining indicator, reason for prescribing was recorded for 48% and 76% of medicines respectively in IU and CU. After intervention, only three indicators, medicines that had the reason for prescription recorded in the patient records, children treated without regular medicines, and children received the recommended doses of paracetamol, showed favourable changes in three months and one year. Percentage of medicines written in abbreviation showed an undesirable increase in IU (6.9, 16.2, 29.6) which was higher than what was observed in CU (3.2, 13.5, 18.4). Passive interventions appear to be ineffective in improving RUM in children. In addition, general medicine use indicators seem to be insensitive to capture the true challenges in paediatric pharmacotherapy.